CE

Celanese Corp. Q2 2007 10-Q Summary

Business Context and Reporting Period

This filing covers the quarterly period ended June 30, 2007. Celanese Corporation is an integrated global hybrid chemical company producing value-added chemicals, thermoplastic polymers, and other chemical-based products. The company operates through four primary segments: Chemical Products, Technical Polymers Ticona, Acetate Products, and Performance Products.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 7% for the quarter and 8% for the six-month period compared to 2006, driven by a 3% price increase and favorable currency impacts (Euro), partially offset by a 3% volume decrease.
• Profitability Decline: Operating profit decreased 53% for the quarter and 10% for the six-month period. This was primarily due to significant non-recurring charges.
• Refinancing Charges: The company incurred $256 million in refinancing expenses during the quarter and six months ended June 30, 2007, related to a comprehensive debt recapitalization in April 2007. This included $207 million in premiums on early debt redemption.
• Deferred Compensation: An "Exit Event" triggered by the sale of Original Shareholders' equity resulted in a $74 million charge for deferred compensation plan payments.
• Discontinued Operations: The sale of the oxo products and derivatives businesses generated a pre-tax gain of approximately $47 million for the six-month period, significantly boosting net earnings despite losses in continuing operations.

Guidance, Outlook, and Risks

• Debt Refinancing: In April 2007, the company entered a new senior credit agreement consisting of $2.28 billion in USD term loans and €400 million in Euro term loans due 2014, plus a $650 million revolving facility. This replaced previous high-interest notes and facilities.
• Share Repurchases: The company repurchased approximately $258 million of Series A common stock during the six months ended June 30, 2007. A subsequent authorization allowed for up to $330 million in repurchases, which was completed in July 2007.
• Operational Risks:
  • Clear Lake Outage: An unplanned outage at the Clear Lake, Texas acetic acid facility reduced volumes in the Chemical Products segment. Repairs were ongoing as of July 2007.
  • Legal Proceedings: Significant accruals exist for sorbates antitrust actions ($154 million) and plumbing product liability cases ($66 million).
  • Interest Rate Risk: Following refinancing, the company has significant variable rate debt exposure. A 1% increase in interest rates would increase annual interest expense by approximately $13 million.
• Capital Expenditures: Expected to be approximately $280 million for the full year 2007.

Key Facts for Investor Verification

• Continuing Operations Loss: Verify the sustainability of earnings excluding the $256 million refinancing charge and $74 million deferred compensation charge, as continuing operations reported a loss of $124 million for the quarter.
• Discontinued Operations Impact: Confirm that the $86 million net earnings from discontinued operations (primarily the oxo business sale) are non-recurring and do not reflect core business performance.
• Clear Lake Facility Status: Monitor the resolution of the acetic acid unit outage in Texas, as it directly impacts volume and margins in the largest segment (Chemical Products).
• Debt Covenant Compliance: Verify ongoing compliance with the new senior credit agreement covenants, specifically the First-Lien Senior Secured Leverage Ratio.
• Legal Reserves: Review the adequacy of reserves for the sorbates antitrust litigation and plumbing product liability claims, which total over $200 million in accrued liabilities.